These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 34514203)
1. Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance. Lionaki S; Marinaki S; Liapis G; Kalaitzakis E; Fragkioudaki S; Kalogeropoulos P; Michelakis I; Goules A; Tzioufas AG; Boletis JN Kidney Int Rep; 2021 Sep; 6(9):2425-2435. PubMed ID: 34514203 [TBL] [Abstract][Full Text] [Related]
2. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival. Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P Front Immunol; 2021; 12():625672. PubMed ID: 33841408 [TBL] [Abstract][Full Text] [Related]
3. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters? Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223 [TBL] [Abstract][Full Text] [Related]
4. Circulating C3 levels predict renal and global outcome in patients with renal vasculitis. Villacorta J; Diaz-Crespo F; Acevedo M; Cavero T; Guerrero C; Praga M; Fernandez-Juarez G Clin Rheumatol; 2016 Nov; 35(11):2733-2740. PubMed ID: 27562032 [TBL] [Abstract][Full Text] [Related]
5. Are serum C3 levels or kidney C3 deposits useful markers for predicting outcomes in patients with ANCA-associated vasculitis? Cassard A; Kounde C; Bouillet L; Goulenok T; Ribes D; Mesbah R; Langlois V; Delas A; Fortenfant F; Humbert S; Lebas C; Belliere J; Kerschen P; Chauveau D; Colombat M; Faguer S J Transl Autoimmun; 2023 Dec; 7():100217. PubMed ID: 37877133 [TBL] [Abstract][Full Text] [Related]
6. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis. Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163 [TBL] [Abstract][Full Text] [Related]
7. Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki Brilland B; Wacrenier S; Henry N; Guibert F; Piccoli GB; Augusto JF Kidney Int Rep; 2021 Nov; 6(11):2931-2933. PubMed ID: 34805646 [No Abstract] [Full Text] [Related]
8. Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study. García L; Pena CE; Maldonado RÁ; Costi C; Mamberti M; Martins E; García MA Clin Rheumatol; 2019 Oct; 38(10):2819-2824. PubMed ID: 31222573 [TBL] [Abstract][Full Text] [Related]
9. Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome. Naidu GS; Sharma A; Nada R; Kohli HS; Jha V; Gupta KL; Sakhuja V; Rathi M Rheumatol Int; 2014 Dec; 34(12):1721-7. PubMed ID: 24838685 [TBL] [Abstract][Full Text] [Related]
10. The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries. Lionaki S; Boletis JN Kidney Dis (Basel); 2016 Mar; 1(4):224-34. PubMed ID: 27536682 [TBL] [Abstract][Full Text] [Related]
11. Complement your knowledge with a rare cause of pauci-immune glomerulonephritis. Lomzenski H; Thibodaux R; Guevara M Clin Rheumatol; 2018 Nov; 37(11):3151-3155. PubMed ID: 30203317 [TBL] [Abstract][Full Text] [Related]
12. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Chen M; Xing GQ; Yu F; Liu G; Zhao MH Nephrol Dial Transplant; 2009 Apr; 24(4):1247-52. PubMed ID: 18940884 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognostic risk factors of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV). Chen Z; Lin L; Yang W; Chen N; Lin Y Int Immunopharmacol; 2020 Oct; 87():106819. PubMed ID: 32717565 [TBL] [Abstract][Full Text] [Related]
14. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis. Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415 [TBL] [Abstract][Full Text] [Related]
15. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN. Zhao L; David MZ; Hyjek E; Chang A; Meehan SM Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918 [TBL] [Abstract][Full Text] [Related]
17. Something Out of Nothing: A Rare Case of Pulmonary Renal Syndrome With Pauci-Immune Glomerulonephritis and Diffuse Alveolar Hemorrhage With Negative Serologies. Wang LJ; Collazo-Maldonado R Cureus; 2021 Oct; 13(10):e18614. PubMed ID: 34765369 [TBL] [Abstract][Full Text] [Related]
18. Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Day CJ; Howie AJ; Nightingale P; Shabir S; Adu D; Savage CO; Hewins P Am J Kidney Dis; 2010 Feb; 55(2):250-8. PubMed ID: 20045237 [TBL] [Abstract][Full Text] [Related]